COMPANY

SUN PHARMACEUTICAL INDUSTRIES INC

SUN PHARMACEUTICAL INDUSTRIES INC: bulk ingredient labeler, US labeler, recalling firm for Exenatide, Icatibant, Lanreotide, Leuprolide, Linaclotide, Liraglutide, Octreotide, Pramlintide, Teriparatide, Bacitracin, Desmopressin, Ganirelix, as stated by public registers.

Also written as: Sun Pharmaceutical Industries, Inc.; SUN PHARMACEUTICAL INDUSTRIES, INC..

BULK INGREDIENT LABELER

Lists the bulk active ingredient with FDA (NDC directory).

ExenatideExenatide, BULK INGREDIENT Regulator openFDA
IcatibantIcatibant acetate, BULK INGREDIENT Regulator openFDA
LanreotideLanreotide Acetate, BULK INGREDIENT Regulator openFDA
LeuprolideLeuprolide Acetate, BULK INGREDIENT Regulator openFDA
LinaclotideLinaclotide, BULK INGREDIENT Regulator openFDA
LiraglutideLiraglutide, BULK INGREDIENT Regulator openFDA
OctreotideOctreotide Acetate, BULK INGREDIENT Regulator openFDA
PramlintidePramlintide Acetate, BULK INGREDIENT Regulator openFDA
TeriparatideTeriparatide, BULK INGREDIENT Regulator openFDA

US LABELER

Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.

BacitracinBacitracin Zinc, OTC MONOGRAPH DRUG Regulator openFDA
BacitracinDouble Antibiotic, OTC MONOGRAPH DRUG Regulator openFDA
BacitracinTriple Antibiotic Plus Pain Relief, OTC MONOGRAPH DRUG Regulator openFDA
BacitracinTriple Antibiotic, OTC MONOGRAPH DRUG Regulator openFDA
DesmopressinDesmopressin Acetate, ANDA Regulator openFDA
Leuprolideleuprolide acetate, ANDA Regulator openFDA
OctreotideBYNFEZIA Pen, NDA Regulator openFDA

RECALLING FIRM

Recalled a product naming the peptide (FDA enforcement report).

GanirelixClass II recall, Terminated, 2021-04-14 Regulator openFDA

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.